News Release

Association between buprenorphine treatment gaps, opioid overdose, health care spending

JAMA Psychiatry

Peer-Reviewed Publication

JAMA Network

About The Study: Nonadherence with the opioid use disorder medication buprenorphine was associated with an increased risk of experiencing an opioid overdose and higher health care expenditures in this study that included 34,000 Medicare patients.

Authors: Jason B. Gibbons, Ph.D., of the Johns Hopkins University Bloomberg School of Public Health in Baltimore, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(10.1001/jamapsychiatry.2022.3118)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.3118?guestAccessKey=342b3db0-6e81-445c-ac0f-8055c8171082&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100522


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.